Roche CEO: No Plans to Sell Diabetes Business

The transcript discusses the challenges faced by the industry, particularly in the diabetes care segment. It highlights the company's performance, noting that the diagnostics division has grown by 7% in local currencies, despite a decline in the diabetes care market. The company remains committed to this segment, emphasizing its market leadership and rejecting any plans to sell the unit, even for $5 billion.

What issue is the industry currently facing according to the speaker?

• Regulatory changes

• High employee turnover

• Treatment challenges

• Lack of innovation

What percentage of total sales does the diabetes scale account for?

• 15%

• 4%

• 7%

• 10%

How did the diagnostics division perform overall?

• It declined by 5%

• It remained stable

• It grew by 7% in local currencies

• It grew by 10% in local currencies

What is the company's position in the diabetes care segment?

• A new entrant

• A minor player

• A market leader

• An average competitor

What is the company's stance on selling the diabetes care unit?

• They are committed to keeping it

• They have already sold it

• They plan to sell it soon

• They are considering offers